Use and outcomes of the PK Papyrus covered stent in France: SOS PK Papyrus Registry
- PMID: 33085150
- DOI: 10.1002/ccd.29328
Use and outcomes of the PK Papyrus covered stent in France: SOS PK Papyrus Registry
Abstract
Objectives: To evaluate the rate of procedural success and long-term outcomes of the PK Papyrus (PKP) covered stent (CS).
Background: CS are essential in the treatment of coronary artery perforation (CAP). They have also been used to treat coronary artery aneurysms. Limited evidence is available on clinical outcomes with the PKP.
Methods: This was a multicenter, observational, retrospective, and prospective study. Consecutive patients undergoing intentional PKP implantation in 22 centers in France were included. The primary endpoint was the rate of procedural success. Secondary endpoints included rates of death, myocardial infarction (MI), target lesion revascularization (TLR), in-stent restenosis (ISR), and stent thrombosis (ST).
Results: Data from 130 patients were analyzed (mean age 72.5 ± 10.5 years; 71% men). The main indication for PKP was CAP, in 84 patients (65%). Delivery success was achieved in 95% and procedural success in 91%. During the in-hospital stay, 15 patients died (12%) and 7 (5%) presented with ST. Data from 127 patients were available at 19.2 ± 12.8 month follow-up. Thirty-three patients died (26%), 15 (12%) had an MI and 21 (17%) presented with TLR. TLR was due to ISR in 12 patients (9%), 10 had definite ST (8%) and 1 patient for stent under-expansion.
Conclusions: The principal indication for PKP was CAP. PKP had high rates of delivery and procedural success. At long-term follow-up, there was a high rate of TLR, mainly due to ISR and ST. These results are consistent with previously reported data in these clinical settings.
Keywords: Papyrus; coronary aneurysm; coronary perforation; covered stent; outcomes.
© 2020 Wiley Periodicals LLC.
Comment in
-
What have we learnt from the use of papyrus covered stent in France and Spain?Catheter Cardiovasc Interv. 2021 Aug 1;98(2):410. doi: 10.1002/ccd.29469. Epub 2021 Jan 23. Catheter Cardiovasc Interv. 2021. PMID: 33484045 No abstract available.
-
Reply to "what have we learnt from the use of Papyrus covered stent in France and Spain?".Catheter Cardiovasc Interv. 2021 Aug 1;98(2):411-412. doi: 10.1002/ccd.29462. Epub 2021 Jan 23. Catheter Cardiovasc Interv. 2021. PMID: 33484048 No abstract available.
-
Covered stents: Initially life-saving but long-term consequences persist.Catheter Cardiovasc Interv. 2021 Nov 1;98(5):882-883. doi: 10.1002/ccd.29980. Catheter Cardiovasc Interv. 2021. PMID: 34752010 No abstract available.
References
REFERENCES
-
- Heuser RR, Reynolds GT, Papazoglou C, Diethrich EB. Endoluminal grafting for percutaneous aneurysm exclusion in an aortocoronary saphenous vein graft: the first clinical experience. J Endovasc Surg. 1995;2(1):81-88. https://doi.org/10.1583/1074-6218(1995)002<0081:EGFPAE>2.0.CO;2.
-
- Stankovic G, Colombo A, Presbitero P, et al. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts. Circulation. 2003;108(1):37-42.
-
- Briguori C, Nishida T, Anzuini A, Di Mario C, Grube E, Colombo A. Emergency polytetrafluoroethylene-covered stent implantation to treat coronary ruptures. Circulation. 2000;102(25):3028-3031.
-
- Kawamoto H, Tanaka K, Ruparelia N, et al. Short-term and long-term outcomes after polytetrafluoroethylene-covered stent implantation for the treatment of coronary perforation. Am J Cardiol. 2015;116(12):1822-1826. https://doi.org/10.1016/j.amjcard.2015.09.019.
-
- Lattuca B, Schmutz L, Cornillet L, et al. New polyurethane covered stent with low profile for treatment of a large aneurysm after left anterior descending artery stenting: first experience. Int J Cardiol. 2015;201:208-209. https://doi.org/10.1016/j.ijcard.2015.08.036.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous